ArticleEuropean heart journal open2025

Effect of empagliflozin on reducing the no-reflow phenomenon in patients with ST-elevation myocardial infarction: rationale and design of the EMPA-PCI trial.

Fabio Solis-Jimenez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.